Outcomes with and without outpatient SARS-CoV-2 treatment for patients with COVID-19 and systemic autoimmune rheumatic diseases: a retrospective cohort study

Mostrar otras versiones (1)

BACKGROUND: Some patients with systemic autoimmune rheumatic disease and immunosuppression might still be at risk of severe COVID-19. The effect of outpatient SARS-CoV-2 treatments on COVID-19 outcomes among patients with systemic autoimmune rheumatic disease is unclear. We aimed to evaluate tempora...

Descripción completa

Detalles Bibliográficos
Autores principales: Qian, Grace, Wang, Xiaosong, Patel, Naomi J, Kawano, Yumeko, Fu, Xiaoqing, Cook, Claire E, Vanni, Kathleen M M, Kowalski, Emily N, Banasiak, Emily P, Bade, Katarina J, Srivatsan, Shruthi, Williams, Zachary K, Todd, Derrick J, Weinblatt, Michael E, Wallace, Zachary S, Sparks, Jeffrey A
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier Ltd. 2023
Materias:
Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9940330/
https://www.ncbi.nlm.nih.gov/pubmed/36844970
http://dx.doi.org/10.1016/S2665-9913(23)00006-1

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9940330/
https://www.ncbi.nlm.nih.gov/pubmed/36844970
http://dx.doi.org/10.1016/S2665-9913(23)00006-1

Ejemplares similares